Co-Diagnostics (CODX) Q3 2025 Earnings Transcript

Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...
Le Lézard

New England Biolabs® launches the NEBNext® Flu A Integrated Indexing Primer Module to ...

New England Biolabs (NEB®) today announces the release of the NEBNext Flu A Integrated Indexing Primer Module (NEB #E3436), designed to streamline and scale the sequencing of Influenza A virus from a ...